Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHD
Public ClinicalTrials.gov record NCT00315276. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 9-week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With Attention Deficit/Hyperactivity Disorder
Study identification
- NCT ID
- NCT00315276
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Cephalon
- Industry
- Enrollment
- 370 participants
Conditions and interventions
Conditions
Interventions
- Modafinil Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2006
- Primary completion
- Not listed
- Completion
- Dec 31, 2006
- Last update posted
- Aug 23, 2012
2006 – 2007
United States locations
- U.S. sites
- 18
- U.S. states
- 15
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Neurology Clinical Study Centers, LLC | Little Rock | Arkansas | 72205 | — |
| Bay Area Research Institute | Lafayette | California | 94549 | — |
| Pharmacology Research Institute | Northridge | California | 91324 | — |
| Peninsula Research Associates | Rolling Hills Estates | California | 90274 | — |
| UCSD Medical Center | San Diego | California | 92103 | — |
| Clinical Neuroscience Solution, Inc. | Orlando | Florida | 32806 | — |
| University of Illinois | Chicago | Illinois | 60608 | — |
| Michael J. Reiser, MD, LLC | Lexington | Kentucky | 40509 | — |
| Adult ADD Center of Maryland | Lutherville | Maryland | 21093 | — |
| Massachusetts General Hospital | Cambridge | Massachusetts | 02138 | — |
| Rochester Center for Behavioral Medicine | Rochester | Michigan | 48307 | — |
| CRI WorldWide, LLC | Clementon | New Jersey | 08021 | — |
| New York University | New York | New York | 10010 | — |
| Summit Research Network Inc. | Portland | Oregon | 97210 | — |
| CRI WorldWide, LLC | Philadelphia | Pennsylvania | 19149 | — |
| South East Health Consultants, LLC | Charleston | South Carolina | 29407 | — |
| Clinical Neuroscience Solution | Memphis | Tennessee | 38119 | — |
| Neuropsychiatric Associates | Woodstock | Vermont | 05091 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00315276, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 23, 2012 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00315276 live on ClinicalTrials.gov.